Clinical Trials Directory

Trials / Completed

CompletedNCT02666807

Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes Mellitus

Effects of Oral Ginger Supplementation on NF-KB (Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells) in Peripheral Blood Mononuclear Cells (PBMC) and Glycemic and Lipid Profiles in Patients With Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effect of ginger on NF-KB level in Peripheral Blood Mononuclear Cells in type 2 diabetic patients. Half of patients will receive ginger, while the other half will receive placebo.

Detailed description

ginger is a plant with lots of phytochemicals which have antioxidant effects. It reduces the NF-KB levels in the cells because of its antioxidant effects. It can reduces insulin resistance as a result of NF-KB reduction in diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGingerGinger 500 mg capsules (2000 mg per day) by mouth twice daily (BID) for 10 weeks
DIETARY_SUPPLEMENTplaceboPlacebo matching with ginger 0 mg capsules by mouth twice daily (BID) for 10 weeks

Timeline

Start date
2015-06-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2016-01-28
Last updated
2016-01-28

Source: ClinicalTrials.gov record NCT02666807. Inclusion in this directory is not an endorsement.